Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morena Spreafico

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Current Topics in Medicinal Chemistry|April 13, 2013
In silico prediction of brain exposure: drug free fraction, unbound brain to plasma concentration ratio and equilibrium half-lifeMorena Spreafico, Matthew P Jacobson
Molecular Diversity|March 6, 2008
Structural features of diverse ligands influencing binding affinities to estrogen alpha and estrogen beta receptors. Part I: Molecular descriptors calculated from minimal energy conformation of isolated ligandsElena Boriani, Morena Spreafico, Emilio Benfenati, et al.
Molecular Diversity|March 5, 2008
Structural features of diverse ligands influencing binding affinities to estrogen alpha and estrogen beta receptors. Part II. Molecular descriptors calculated from conformation of the ligands in the complex resulting from previous docking studyMorena Spreafico, Elena Boriani, Emilio Benfenati, et al.
Toxicology Letters|July 24, 2007
Predicting the toxic potential of drugs and chemicals in silico: a model for the peroxisome proliferator-activated receptor gamma (PPAR gamma)Angelo Vedani, Anne-Vérène Descloux, Morena Spreafico, et al.
ALTEX|November 13, 2009
VirtualToxLab - in silico prediction of the toxic (endocrine-disrupting) potential of drugs, chemicals and natural products. Two years and 2,000 compounds of experience: a progress reportAngelo Vedani, Martin Smiesko, Morena Spreafico, et al.
Toxicology Letters|June 16, 2009
Mixed-model QSAR at the human mineralocorticoid receptor: predicting binding mode and affinity of anabolic steroidsOurania Peristera, Morena Spreafico, Martin Smiesko, et al.
ALTEX|September 25, 2007
VirtualToxLab - in silico prediction of the toxic potential of drugs and environmental chemicals: evaluation status and internet access protocolAngelo Vedani, Max Dobler, Morena Spreafico, et al.
Molecular Informatics|July 28, 2016
Probing Small-Molecule Binding to the Liver-X Receptor: A Mixed-Model QSAR StudyMorena Spreafico, Martin Smiesko, Ourania Peristera, et al.
Chemmedchem|November 2, 2010
Probing small-molecule binding to cytochrome P450 2D6 and 2C9: An in silico protocol for generating toxicity alertsGianluca Rossato, Beat Ernst, Martin Smiesko, et al.
Chemmedchem|November 15, 2008
Mixed-model QSAR at the glucocorticoid receptor: predicting the binding mode and affinity of psychotropic drugsMorena Spreafico, Beat Ernst, Markus A Lill, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Current Topics in Medicinal Chemistry|April 13, 2013
In silico prediction of brain exposure: drug free fraction, unbound brain to plasma concentration ratio and equilibrium half-lifeMorena Spreafico, Matthew P Jacobson
Molecular Diversity|March 6, 2008
Structural features of diverse ligands influencing binding affinities to estrogen alpha and estrogen beta receptors. Part I: Molecular descriptors calculated from minimal energy conformation of isolated ligandsElena Boriani, Morena Spreafico, Emilio Benfenati, et al.
Molecular Diversity|March 5, 2008
Structural features of diverse ligands influencing binding affinities to estrogen alpha and estrogen beta receptors. Part II. Molecular descriptors calculated from conformation of the ligands in the complex resulting from previous docking studyMorena Spreafico, Elena Boriani, Emilio Benfenati, et al.
Toxicology Letters|July 24, 2007
Predicting the toxic potential of drugs and chemicals in silico: a model for the peroxisome proliferator-activated receptor gamma (PPAR gamma)Angelo Vedani, Anne-Vérène Descloux, Morena Spreafico, et al.
ALTEX|November 13, 2009
VirtualToxLab - in silico prediction of the toxic (endocrine-disrupting) potential of drugs, chemicals and natural products. Two years and 2,000 compounds of experience: a progress reportAngelo Vedani, Martin Smiesko, Morena Spreafico, et al.
Toxicology Letters|June 16, 2009
Mixed-model QSAR at the human mineralocorticoid receptor: predicting binding mode and affinity of anabolic steroidsOurania Peristera, Morena Spreafico, Martin Smiesko, et al.
ALTEX|September 25, 2007
VirtualToxLab - in silico prediction of the toxic potential of drugs and environmental chemicals: evaluation status and internet access protocolAngelo Vedani, Max Dobler, Morena Spreafico, et al.
Molecular Informatics|July 28, 2016
Probing Small-Molecule Binding to the Liver-X Receptor: A Mixed-Model QSAR StudyMorena Spreafico, Martin Smiesko, Ourania Peristera, et al.
Chemmedchem|November 2, 2010
Probing small-molecule binding to cytochrome P450 2D6 and 2C9: An in silico protocol for generating toxicity alertsGianluca Rossato, Beat Ernst, Martin Smiesko, et al.
Chemmedchem|November 15, 2008
Mixed-model QSAR at the glucocorticoid receptor: predicting the binding mode and affinity of psychotropic drugsMorena Spreafico, Beat Ernst, Markus A Lill, et al.
Pageof 2